B-cell malignancies

Jennifer B. Dunlap, Guang Fan, Nicky Leeborg, Rita M. Braziel

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Scopus citations


The mature B-cell neoplasms include numerous subtypes of B-cell leukemias and lymphomas (BCL), as well as plasma cell neoplasms. BCL represent 80-90 % of mature lymphoid leukemias and non-Hodgkin lymphomas (NHL) in the Western world. BCL subtypes include numerous distinct diseases, with different biologies, natural histories, morphologic characteristics, immunophenotypes, genetic features, prognoses, and responses to therapy. BCL also include the majority of immunodeficiency-associated lymphomas. Accurate subclassification of BCL has been a challenge for pathologists, resulting in early application of new techniques in molecular analysis to improve diagnostic accuracy. Today, the molecular features of BCL are used to aid in rendering an accurate diagnosis, to predict prognosis, to help determine optimal therapy, and to assess for minimal residual disease (MRD) after therapy. The molecular abnormalities in BCL have commonly been evaluated for clinical purposes, including those occurring in genes coding for antigen receptor (AgR) molecules and those occurring in oncogenes and tumor suppressor genes. This chapter will discuss current molecular testing methods for BCL, as well as some of the newer methods being developed for BCL.

Original languageEnglish (US)
Title of host publicationMolecular Pathology in Clinical Practice:Second Edition
PublisherSpringer International Publishing
Number of pages24
ISBN (Electronic)9783319196749
ISBN (Print)9783319196732
StatePublished - Jan 1 2016


  • B-cell leukemia
  • B-cell lymphoma
  • Immunodeficiency-associated lymphoma
  • Immunoglobulin receptor gene rearrangement
  • Molecular testing
  • Non-Hodgkin lymphoma
  • Oncogenes
  • Tumor suppressor genes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'B-cell malignancies'. Together they form a unique fingerprint.

Cite this